ORA - Oxford University Research Archive

1 - 8 of 8

1

Journal article

Half-life of exogenous growth hormone following suppression of endogenous growth hormone secretion with somatostatin in type I (insulin-dependent) diabetes mellitus.

Mullis, PE, Pal, BR, Matthews, DR, et al.
1992-03-05

2

Journal article

Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release

Pes, R, Godar, SC, Fox, AT, et al.
2016-11-23

3

Journal article

Dopamine-associated cached values are not sufficient as the basis for action selection.

Hollon, NG, Arnold, MM, Gan, JO, et al.
2014-12-05

4

Journal article

Evidence for a role for insulin and growth hormone in overnight regulation of 3-hydroxybutyrate in normal and diabetic adolescents.

Edge, JA, Harris, DA, Phillips, PE, et al.
1993-07-05

5

Journal article

Dissociable cost and benefit encoding of future rewards by mesolimbic dopamine.

Gan, JO, Walton, ME, Phillips, PE
2010-01-05

6

Journal article

Weighing up the benefits of work: behavioral and neural analyses of effort-related decision making.

Walton, ME, Kennerley, SW, Bannerman, DM, et al.
2006-10-05

7

Journal article

Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine.

Phillips, PE, Walton, ME, Jhou, TC
2007-04-05

8

Journal article

Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus.

Pal, BR, Phillips, PE, Matthews, DR, et al.
1992-06-05

TO TOP